

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of B cell apoptotic process (GO:0002903) | 7.98753821 |
| 2 | V(D)J recombination (GO:0033151) | 7.97962511 |
| 3 | purine deoxyribonucleotide catabolic process (GO:0009155) | 7.79258526 |
| 4 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 6.69338922 |
| 5 | deoxyribonucleotide catabolic process (GO:0009264) | 6.44066412 |
| 6 | positive regulation by host of viral transcription (GO:0043923) | 6.35183080 |
| 7 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 6.21532972 |
| 8 | regulation of histone H3-K9 methylation (GO:0051570) | 6.12436157 |
| 9 | deoxyribose phosphate catabolic process (GO:0046386) | 6.08920783 |
| 10 | DNA unwinding involved in DNA replication (GO:0006268) | 5.86406437 |
| 11 | purine deoxyribonucleotide metabolic process (GO:0009151) | 5.68384868 |
| 12 | purine nucleotide salvage (GO:0032261) | 5.65703825 |
| 13 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 5.62208608 |
| 14 | autophagic vacuole fusion (GO:0000046) | 5.57409998 |
| 15 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 5.53852255 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 5.35371482 |
| 17 | protein localization to kinetochore (GO:0034501) | 5.33548633 |
| 18 | nucleotide salvage (GO:0043173) | 5.31663082 |
| 19 | regulation of B cell apoptotic process (GO:0002902) | 5.19819866 |
| 20 | negative regulation of histone methylation (GO:0031061) | 5.14467656 |
| 21 | protein-DNA complex disassembly (GO:0032986) | 5.09519779 |
| 22 | nucleosome disassembly (GO:0006337) | 5.09519779 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 5.06957046 |
| 24 | natural killer cell differentiation (GO:0001779) | 5.02988662 |
| 25 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.99995145 |
| 26 | regulation of growth of symbiont in host (GO:0044126) | 4.99995145 |
| 27 | negative regulation of growth of symbiont in host (GO:0044130) | 4.99995145 |
| 28 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.99995145 |
| 29 | cellular hyperosmotic response (GO:0071474) | 4.93932980 |
| 30 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 4.88568772 |
| 31 | DNA topological change (GO:0006265) | 4.79597960 |
| 32 | L-serine transport (GO:0015825) | 4.78767810 |
| 33 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.70553567 |
| 34 | serine transport (GO:0032329) | 4.68585812 |
| 35 | lens fiber cell development (GO:0070307) | 4.66383288 |
| 36 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.61260161 |
| 37 | protein localization to chromosome, centromeric region (GO:0071459) | 4.61041904 |
| 38 | deoxyribose phosphate metabolic process (GO:0019692) | 4.58935280 |
| 39 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.55406111 |
| 40 | organelle membrane fusion (GO:0090174) | 4.53896672 |
| 41 | positive regulation of granulocyte differentiation (GO:0030854) | 4.50872783 |
| 42 | sister chromatid segregation (GO:0000819) | 4.43898021 |
| 43 | mitotic sister chromatid cohesion (GO:0007064) | 4.41606814 |
| 44 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.36531184 |
| 45 | vesicle targeting (GO:0006903) | 4.33328934 |
| 46 | mature B cell differentiation involved in immune response (GO:0002313) | 4.25698715 |
| 47 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.20850711 |
| 48 | Peyers patch development (GO:0048541) | 4.20850711 |
| 49 | positive regulation of histone deacetylation (GO:0031065) | 4.17736925 |
| 50 | B cell proliferation (GO:0042100) | 4.17716149 |
| 51 | tachykinin receptor signaling pathway (GO:0007217) | 4.17496013 |
| 52 | T cell lineage commitment (GO:0002360) | 4.17376073 |
| 53 | negative regulation of phagocytosis (GO:0050765) | 4.11866064 |
| 54 | deoxyribonucleotide metabolic process (GO:0009262) | 4.09447476 |
| 55 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.08468150 |
| 56 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.08468150 |
| 57 | ribosomal small subunit assembly (GO:0000028) | 4.07342047 |
| 58 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 4.04420821 |
| 59 | somatic cell DNA recombination (GO:0016444) | 4.04420821 |
| 60 | mitotic sister chromatid segregation (GO:0000070) | 4.02036019 |
| 61 | base-excision repair, AP site formation (GO:0006285) | 3.99595388 |
| 62 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.92162197 |
| 63 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.90333578 |
| 64 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.87631610 |
| 65 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.86065378 |
| 66 | regulation of mitochondrial translation (GO:0070129) | 3.85618939 |
| 67 | positive regulation of chromosome segregation (GO:0051984) | 3.83280217 |
| 68 | establishment of integrated proviral latency (GO:0075713) | 3.82165000 |
| 69 | regulation of chemokine biosynthetic process (GO:0045073) | 3.80696923 |
| 70 | positive regulation of vascular permeability (GO:0043117) | 3.73697649 |
| 71 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.70962724 |
| 72 | somatic diversification of immune receptors (GO:0002200) | 3.70470992 |
| 73 | regulation of germinal center formation (GO:0002634) | 3.67104326 |
| 74 | negative regulation of RNA splicing (GO:0033119) | 3.66280373 |
| 75 | DNA strand elongation (GO:0022616) | 3.65988125 |
| 76 | histamine secretion (GO:0001821) | 3.65243962 |
| 77 | regulation of penile erection (GO:0060405) | 3.64546950 |
| 78 | regulation of DNA endoreduplication (GO:0032875) | 3.64465454 |
| 79 | negative regulation of cell size (GO:0045792) | 3.64412596 |
| 80 | regulation of granulocyte differentiation (GO:0030852) | 3.64407102 |
| 81 | DNA ligation (GO:0006266) | 3.63468905 |
| 82 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.62603537 |
| 83 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.62509648 |
| 84 | viral transcription (GO:0019083) | 3.59634896 |
| 85 | protein complex biogenesis (GO:0070271) | 3.58365216 |
| 86 | immunoglobulin mediated immune response (GO:0016064) | 3.58268052 |
| 87 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.57374263 |
| 88 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.56566108 |
| 89 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.56566108 |
| 90 | NADH dehydrogenase complex assembly (GO:0010257) | 3.56566108 |
| 91 | mannosylation (GO:0097502) | 3.55733222 |
| 92 | mitotic chromosome condensation (GO:0007076) | 3.55621748 |
| 93 | modulation by host of symbiont transcription (GO:0052472) | 3.54547618 |
| 94 | modulation by host of viral transcription (GO:0043921) | 3.54547618 |
| 95 | response to vitamin E (GO:0033197) | 3.53381733 |
| 96 | negative regulation of gene expression, epigenetic (GO:0045814) | 3.50911838 |
| 97 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.48981642 |
| 98 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.48981642 |
| 99 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.48981642 |
| 100 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.48458037 |
| 101 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.47039191 |
| 102 | UV protection (GO:0009650) | 3.46955376 |
| 103 | negative regulation of bone resorption (GO:0045779) | 3.45439596 |
| 104 | cellular extravasation (GO:0045123) | 3.44339445 |
| 105 | mitotic recombination (GO:0006312) | 3.44303437 |
| 106 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.42963344 |
| 107 | mitochondrial calcium ion transport (GO:0006851) | 3.42705467 |
| 108 | translational termination (GO:0006415) | 3.38551343 |
| 109 | positive regulation of lamellipodium assembly (GO:0010592) | 3.36959281 |
| 110 | cellular response to interferon-beta (GO:0035458) | 3.35875991 |
| 111 | purine-containing compound salvage (GO:0043101) | 3.34845508 |
| 112 | chromatin silencing (GO:0006342) | 3.34166557 |
| 113 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.32484164 |
| 114 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.32122780 |
| 115 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.31542805 |
| 116 | protein localization to chromosome (GO:0034502) | 3.30569696 |
| 117 | regulation of histone methylation (GO:0031060) | 3.29675034 |
| 118 | T cell homeostasis (GO:0043029) | 3.28240687 |
| 119 | iron-sulfur cluster assembly (GO:0016226) | 3.27931798 |
| 120 | metallo-sulfur cluster assembly (GO:0031163) | 3.27931798 |
| 121 | pyrimidine-containing compound salvage (GO:0008655) | 3.27918151 |
| 122 | pyrimidine nucleoside salvage (GO:0043097) | 3.27918151 |
| 123 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.27736578 |
| 124 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 3.27283879 |
| 125 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.23309746 |
| 126 | positive regulation of Rap GTPase activity (GO:0032854) | 3.23177215 |
| 127 | ATP-dependent chromatin remodeling (GO:0043044) | 3.22988238 |
| 128 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.22517839 |
| 129 | translesion synthesis (GO:0019985) | 3.22127851 |
| 130 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 3.21211831 |
| 131 | telomere maintenance via recombination (GO:0000722) | 3.20521822 |
| 132 | B cell differentiation (GO:0030183) | 3.18884906 |
| 133 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.18741564 |
| 134 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.17374710 |
| 135 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.17374710 |
| 136 | pseudouridine synthesis (GO:0001522) | 3.16559121 |
| 137 | lipopolysaccharide metabolic process (GO:0008653) | 3.16504012 |
| 138 | cGMP-mediated signaling (GO:0019934) | 3.16426560 |
| 139 | positive regulation of protein deacetylation (GO:0090312) | 3.14823940 |
| 140 | translational elongation (GO:0006414) | 3.14312415 |
| 141 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.13220078 |
| 142 | DNA duplex unwinding (GO:0032508) | 3.11112845 |
| 143 | negative regulation of granulocyte differentiation (GO:0030853) | 3.10430516 |
| 144 | DNA geometric change (GO:0032392) | 3.08322152 |
| 145 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07872439 |
| 146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.07872439 |
| 147 | regulation of B cell differentiation (GO:0045577) | 3.06614321 |
| 148 | cytochrome complex assembly (GO:0017004) | 3.05892896 |
| 149 | protein complex disassembly (GO:0043241) | 3.05023987 |
| 150 | adaptation of signaling pathway (GO:0023058) | 3.04292828 |
| 151 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.03262123 |
| 152 | neutrophil mediated immunity (GO:0002446) | 3.02565762 |
| 153 | regulation of extracellular matrix disassembly (GO:0010715) | 3.01462091 |
| 154 | hepatocyte apoptotic process (GO:0097284) | 3.01031579 |
| 155 | establishment of viral latency (GO:0019043) | 3.00723397 |
| 156 | determination of adult lifespan (GO:0008340) | 3.00042446 |
| 157 | mature B cell differentiation (GO:0002335) | 2.97103329 |
| 158 | nucleoside salvage (GO:0043174) | 2.96978876 |
| 159 | purine nucleobase biosynthetic process (GO:0009113) | 2.96227233 |
| 160 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.95836869 |
| 161 | DNA deamination (GO:0045006) | 2.93998779 |
| 162 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.93946412 |
| 163 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92572997 |
| 164 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91530324 |
| 165 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.90782831 |
| 166 | chaperone-mediated protein transport (GO:0072321) | 2.90092693 |
| 167 | seminiferous tubule development (GO:0072520) | 2.89459091 |
| 168 | negative regulation of multicellular organism growth (GO:0040015) | 2.84816555 |
| 169 | B cell mediated immunity (GO:0019724) | 2.83718386 |
| 170 | mast cell degranulation (GO:0043303) | 2.83489170 |
| 171 | mast cell activation involved in immune response (GO:0002279) | 2.83489170 |
| 172 | reactive oxygen species biosynthetic process (GO:1903409) | 2.82318917 |
| 173 | histamine transport (GO:0051608) | 2.81384089 |
| 174 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.80851812 |
| 175 | lymphocyte homeostasis (GO:0002260) | 2.80524111 |
| 176 | ribosomal small subunit biogenesis (GO:0042274) | 2.80209887 |
| 177 | negative regulation of mRNA processing (GO:0050686) | 2.79446593 |
| 178 | DNA replication initiation (GO:0006270) | 2.78565003 |
| 179 | positive regulation of prostaglandin secretion (GO:0032308) | 2.74439945 |
| 180 | response to interferon-beta (GO:0035456) | 2.73636089 |
| 181 | fucose catabolic process (GO:0019317) | 2.72422331 |
| 182 | L-fucose metabolic process (GO:0042354) | 2.72422331 |
| 183 | L-fucose catabolic process (GO:0042355) | 2.72422331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 6.34038568 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.77817849 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.99044984 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.76829954 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.37001530 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.32287190 |
| 7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.13193576 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.05586136 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.90650094 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.69054828 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.53674503 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.51169807 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46143252 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.45208355 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.43081647 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.33704344 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29656631 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28938497 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23114890 |
| 20 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.19956238 |
| 21 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.17356136 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.16398839 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16257971 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14643185 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.07506834 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07219076 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00376041 |
| 28 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.00324058 |
| 29 | E2F7_22180533_ChIP-Seq_HELA_Human | 10.7582903 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.99462433 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.97637481 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.93871862 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92188265 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.91596030 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89251144 |
| 36 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89020807 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.88856750 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.88730740 |
| 39 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.86908329 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.84651448 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83864512 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75547154 |
| 43 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.72652999 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72185028 |
| 45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.71875326 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70883819 |
| 47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.66861024 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63453227 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.62515048 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.61096169 |
| 51 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.60098983 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.59907785 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.59053238 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58988439 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.58437710 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58357028 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57822302 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57307660 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.56011782 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53644063 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52532867 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.51777127 |
| 63 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.51083636 |
| 64 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51039749 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48468804 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.45596403 |
| 67 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.43565912 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43130521 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42325894 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.41021654 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39747290 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39194648 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38859454 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.34102702 |
| 75 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.33963004 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33679762 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30810993 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29580328 |
| 79 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.28702831 |
| 80 | P68_20966046_ChIP-Seq_HELA_Human | 1.27228596 |
| 81 | P300_27268052_Chip-Seq_Bcells_Human | 1.27063738 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 1.25350433 |
| 83 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.25322461 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23566325 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22928059 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22914594 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22409747 |
| 88 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.22029155 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21681331 |
| 90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20684331 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20585674 |
| 92 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20152128 |
| 93 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18119726 |
| 94 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17796768 |
| 95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16170967 |
| 96 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.15148296 |
| 97 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14138500 |
| 98 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12468553 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12067022 |
| 100 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11960566 |
| 101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11469228 |
| 102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11233521 |
| 103 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11032409 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.11021911 |
| 105 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09699102 |
| 106 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09555162 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09166431 |
| 108 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08431413 |
| 109 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07996028 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06734136 |
| 111 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06388675 |
| 112 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06349353 |
| 113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05948398 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04227608 |
| 115 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04223304 |
| 116 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03122239 |
| 117 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01043527 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00742595 |
| 119 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00339776 |
| 120 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.99977750 |
| 121 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99894030 |
| 122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.99770225 |
| 123 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.99273145 |
| 124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98054335 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97683150 |
| 126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95723650 |
| 127 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95142190 |
| 128 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95140467 |
| 129 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92755906 |
| 130 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92482828 |
| 131 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91436757 |
| 132 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.89132984 |
| 133 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86363849 |
| 134 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.86118345 |
| 135 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.85548734 |
| 136 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.84325973 |
| 137 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82394810 |
| 138 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82019132 |
| 139 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80091760 |
| 140 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.79779025 |
| 141 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.78426584 |
| 142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77535051 |
| 143 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.75920544 |
| 144 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.74624381 |
| 145 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74525605 |
| 146 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.73386711 |
| 147 | GATA1_22025678_ChIP-Seq_K562_Human | 0.72296103 |
| 148 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71782626 |
| 149 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.71637043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 4.63419675 |
| 2 | MP0009697_abnormal_copulation | 4.52612854 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.68109412 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.67639112 |
| 5 | MP0004808_abnormal_hematopoietic_stem | 3.10339313 |
| 6 | * MP0001800_abnormal_humoral_immune | 2.99858424 |
| 7 | MP0000685_abnormal_immune_system | 2.94758295 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.68248490 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.66735308 |
| 10 | MP0001545_abnormal_hematopoietic_system | 2.66735308 |
| 11 | * MP0002398_abnormal_bone_marrow | 2.64766833 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.52181164 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.51172908 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.49803027 |
| 15 | MP0008057_abnormal_DNA_replication | 2.48987200 |
| 16 | MP0003693_abnormal_embryo_hatching | 2.42934759 |
| 17 | MP0000703_abnormal_thymus_morphology | 2.42927678 |
| 18 | MP0003077_abnormal_cell_cycle | 2.42174337 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 2.36869560 |
| 20 | * MP0000689_abnormal_spleen_morphology | 2.34401346 |
| 21 | * MP0002452_abnormal_antigen_presenting | 2.28918321 |
| 22 | MP0004233_abnormal_muscle_weight | 2.23156715 |
| 23 | MP0002653_abnormal_ependyma_morphology | 2.20027027 |
| 24 | * MP0002722_abnormal_immune_system | 2.19865196 |
| 25 | MP0005387_immune_system_phenotype | 2.15202234 |
| 26 | MP0001790_abnormal_immune_system | 2.15202234 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.14263823 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 2.13228945 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 2.12549483 |
| 30 | * MP0000716_abnormal_immune_system | 2.10156701 |
| 31 | MP0010307_abnormal_tumor_latency | 2.10023883 |
| 32 | MP0005671_abnormal_response_to | 2.05453517 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 2.02410014 |
| 34 | * MP0002420_abnormal_adaptive_immunity | 1.95880321 |
| 35 | MP0003646_muscle_fatigue | 1.95855224 |
| 36 | MP0003303_peritoneal_inflammation | 1.95804215 |
| 37 | MP0009785_altered_susceptibility_to | 1.94690059 |
| 38 | * MP0001819_abnormal_immune_cell | 1.92966297 |
| 39 | * MP0002723_abnormal_immune_serum | 1.91392699 |
| 40 | MP0000490_abnormal_crypts_of | 1.89424962 |
| 41 | MP0002019_abnormal_tumor_incidence | 1.85266246 |
| 42 | MP0004147_increased_porphyrin_level | 1.84076044 |
| 43 | * MP0002429_abnormal_blood_cell | 1.78054203 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.76854180 |
| 45 | MP0004947_skin_inflammation | 1.74959713 |
| 46 | MP0003436_decreased_susceptibility_to | 1.73480115 |
| 47 | MP0001835_abnormal_antigen_presentation | 1.69889003 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.68187106 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.67132979 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.64791882 |
| 51 | MP0006054_spinal_hemorrhage | 1.62546689 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.60829689 |
| 53 | MP0005451_abnormal_body_composition | 1.60232564 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.56026579 |
| 55 | MP0002822_catalepsy | 1.54677455 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.47282991 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.45841438 |
| 58 | MP0005266_abnormal_metabolism | 1.42609141 |
| 59 | MP0001661_extended_life_span | 1.41438101 |
| 60 | MP0003252_abnormal_bile_duct | 1.41266532 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.39826797 |
| 62 | MP0001853_heart_inflammation | 1.39225966 |
| 63 | MP0001730_embryonic_growth_arrest | 1.39076240 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.38386745 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.37946036 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.37864863 |
| 67 | MP0003718_maternal_effect | 1.37431328 |
| 68 | MP0008058_abnormal_DNA_repair | 1.36105060 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.35262225 |
| 70 | MP0000350_abnormal_cell_proliferation | 1.35015180 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.34330303 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.31431887 |
| 73 | MP0008961_abnormal_basal_metabolism | 1.30681993 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 1.29233425 |
| 75 | MP0008873_increased_physiological_sensi | 1.27366510 |
| 76 | MP0009764_decreased_sensitivity_to | 1.25445727 |
| 77 | MP0001764_abnormal_homeostasis | 1.23933266 |
| 78 | MP0002405_respiratory_system_inflammati | 1.23770374 |
| 79 | MP0003186_abnormal_redox_activity | 1.21926147 |
| 80 | MP0005025_abnormal_response_to | 1.21151337 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.20797879 |
| 82 | MP0000462_abnormal_digestive_system | 1.20393175 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 1.15491593 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 1.14977729 |
| 85 | MP0008469_abnormal_protein_level | 1.12534438 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 1.12392899 |
| 87 | MP0000427_abnormal_hair_cycle | 1.11402987 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 1.09254616 |
| 89 | MP0003786_premature_aging | 1.08030718 |
| 90 | MP0002006_tumorigenesis | 1.00980156 |
| 91 | MP0000358_abnormal_cell_content/ | 1.00755307 |
| 92 | MP0000313_abnormal_cell_death | 1.00464244 |
| 93 | MP0009840_abnormal_foam_cell | 0.98650517 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.98072334 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.97193744 |
| 96 | MP0001879_abnormal_lymphatic_vessel | 0.95356994 |
| 97 | MP0002419_abnormal_innate_immunity | 0.94019366 |
| 98 | MP0001873_stomach_inflammation | 0.92737654 |
| 99 | MP0002970_abnormal_white_adipose | 0.91408988 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90051534 |
| 101 | MP0001881_abnormal_mammary_gland | 0.89147596 |
| 102 | MP0003984_embryonic_growth_retardation | 0.88396694 |
| 103 | MP0005166_decreased_susceptibility_to | 0.87736735 |
| 104 | MP0002060_abnormal_skin_morphology | 0.87047967 |
| 105 | MP0001915_intracranial_hemorrhage | 0.86811055 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.85873336 |
| 107 | MP0008872_abnormal_physiological_respon | 0.84416972 |
| 108 | MP0003638_abnormal_response/metabolism_ | 0.84032222 |
| 109 | MP0002080_prenatal_lethality | 0.83918995 |
| 110 | MP0005380_embryogenesis_phenotype | 0.83200207 |
| 111 | MP0001672_abnormal_embryogenesis/_devel | 0.83200207 |
| 112 | MP0009763_increased_sensitivity_to | 0.82897783 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.82561364 |
| 114 | MP0002088_abnormal_embryonic_growth/wei | 0.82206172 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.81615867 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.78630145 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78574235 |
| 118 | MP0000858_altered_metastatic_potential | 0.78502364 |
| 119 | MP0002132_abnormal_respiratory_system | 0.78336263 |
| 120 | MP0005501_abnormal_skin_physiology | 0.78331487 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.77894464 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.75885075 |
| 123 | MP0003075_altered_response_to | 0.73772535 |
| 124 | MP0001533_abnormal_skeleton_physiology | 0.73269043 |
| 125 | MP0009931_abnormal_skin_appearance | 0.72820217 |
| 126 | MP0002160_abnormal_reproductive_system | 0.72688252 |
| 127 | MP0004197_abnormal_fetal_growth/weight/ | 0.72189076 |
| 128 | MP0000477_abnormal_intestine_morphology | 0.70544086 |
| 129 | MP0001697_abnormal_embryo_size | 0.69087350 |
| 130 | MP0000377_abnormal_hair_follicle | 0.68874334 |
| 131 | MP0008932_abnormal_embryonic_tissue | 0.68570677 |
| 132 | MP0003866_abnormal_defecation | 0.68501215 |
| 133 | MP0003943_abnormal_hepatobiliary_system | 0.66972790 |
| 134 | MP0001905_abnormal_dopamine_level | 0.66574459 |
| 135 | MP0000465_gastrointestinal_hemorrhage | 0.66226172 |
| 136 | MP0003566_abnormal_cell_adhesion | 0.65374696 |
| 137 | MP0003787_abnormal_imprinting | 0.65132288 |
| 138 | MP0001663_abnormal_digestive_system | 0.64030139 |
| 139 | MP0002086_abnormal_extraembryonic_tissu | 0.63931993 |
| 140 | MP0008995_early_reproductive_senescence | 0.63204606 |
| 141 | MP0008874_decreased_physiological_sensi | 0.63010133 |
| 142 | MP0008770_decreased_survivor_rate | 0.62325206 |
| 143 | MP0002083_premature_death | 0.57464908 |
| 144 | MP0009672_abnormal_birth_weight | 0.55942852 |
| 145 | MP0005621_abnormal_cell_physiology | 0.55642191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Agammaglobulinemia (HP:0004432) | 8.12756666 |
| 2 | Thyroiditis (HP:0100646) | 7.75881057 |
| 3 | * Cellulitis (HP:0100658) | 7.52648983 |
| 4 | B lymphocytopenia (HP:0010976) | 7.09823125 |
| 5 | Abnormality of B cell number (HP:0010975) | 7.09823125 |
| 6 | * Verrucae (HP:0200043) | 6.56075010 |
| 7 | * Papilloma (HP:0012740) | 6.56075010 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 5.85137581 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 5.48346292 |
| 10 | Hypoplasia of the thymus (HP:0000778) | 5.43143672 |
| 11 | Chronic sinusitis (HP:0011109) | 5.17341145 |
| 12 | Small epiphyses (HP:0010585) | 4.98289019 |
| 13 | Combined immunodeficiency (HP:0005387) | 4.94479590 |
| 14 | Recurrent viral infections (HP:0004429) | 4.49478698 |
| 15 | Vertebral arch anomaly (HP:0008438) | 4.47627539 |
| 16 | Abnormality of the intervertebral disk (HP:0005108) | 4.41898530 |
| 17 | * Meningitis (HP:0001287) | 4.25158952 |
| 18 | Recurrent bronchitis (HP:0002837) | 4.08928246 |
| 19 | Increased IgE level (HP:0003212) | 4.04944139 |
| 20 | * Sepsis (HP:0100806) | 3.98546999 |
| 21 | * Osteomyelitis (HP:0002754) | 3.97909236 |
| 22 | Acute necrotizing encephalopathy (HP:0006965) | 3.96410338 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.94919248 |
| 24 | T lymphocytopenia (HP:0005403) | 3.94877255 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 3.85108141 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.77883975 |
| 27 | Hypoproteinemia (HP:0003075) | 3.75968508 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.70893437 |
| 29 | Abnormality of T cell number (HP:0011839) | 3.64952088 |
| 30 | Mitochondrial inheritance (HP:0001427) | 3.63121034 |
| 31 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.58832529 |
| 32 | Acute encephalopathy (HP:0006846) | 3.42324088 |
| 33 | Hepatocellular necrosis (HP:0001404) | 3.39381066 |
| 34 | Mesangial abnormality (HP:0001966) | 3.22596741 |
| 35 | IgM deficiency (HP:0002850) | 3.17738336 |
| 36 | Eosinophilia (HP:0001880) | 3.17593835 |
| 37 | Microvesicular hepatic steatosis (HP:0001414) | 3.16677560 |
| 38 | Abnormality of the fingertips (HP:0001211) | 3.13931672 |
| 39 | Progressive macrocephaly (HP:0004481) | 3.13796067 |
| 40 | Increased CSF lactate (HP:0002490) | 3.13668315 |
| 41 | Recurrent otitis media (HP:0000403) | 3.11767280 |
| 42 | Hepatic necrosis (HP:0002605) | 3.09632535 |
| 43 | Cerebral palsy (HP:0100021) | 3.06903958 |
| 44 | Hypergammaglobulinemia (HP:0010702) | 3.03733706 |
| 45 | Flattened epiphyses (HP:0003071) | 3.01870396 |
| 46 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.99498285 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.96203970 |
| 48 | Ulnar bowing (HP:0003031) | 2.88546513 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.86528105 |
| 50 | Chronic otitis media (HP:0000389) | 2.85896349 |
| 51 | Cutaneous melanoma (HP:0012056) | 2.85311808 |
| 52 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.85301822 |
| 53 | Absent epiphyses (HP:0010577) | 2.85301822 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.83883001 |
| 55 | Mitral stenosis (HP:0001718) | 2.82678773 |
| 56 | Long eyelashes (HP:0000527) | 2.78992252 |
| 57 | Abnormality of T cells (HP:0002843) | 2.76980715 |
| 58 | Obstructive lung disease (HP:0006536) | 2.75671176 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75671176 |
| 60 | Volvulus (HP:0002580) | 2.75501754 |
| 61 | Abnormality of the thymus (HP:0000777) | 2.73013386 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.71999485 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71999485 |
| 64 | Granulocytopenia (HP:0001913) | 2.71647109 |
| 65 | Abnormal protein glycosylation (HP:0012346) | 2.70821486 |
| 66 | Abnormal glycosylation (HP:0012345) | 2.70821486 |
| 67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.70821486 |
| 68 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.70821486 |
| 69 | Cerebral edema (HP:0002181) | 2.69628812 |
| 70 | Cutis marmorata (HP:0000965) | 2.69098728 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.68935838 |
| 72 | Colitis (HP:0002583) | 2.68286224 |
| 73 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60387030 |
| 74 | Acute lymphatic leukemia (HP:0006721) | 2.60284852 |
| 75 | IgG deficiency (HP:0004315) | 2.57559583 |
| 76 | Multiple enchondromatosis (HP:0005701) | 2.53427949 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.52644189 |
| 78 | * Skin rash (HP:0000988) | 2.47833635 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.46756589 |
| 80 | Abnormality of eosinophils (HP:0001879) | 2.41911497 |
| 81 | Reticulocytopenia (HP:0001896) | 2.39946310 |
| 82 | Arthropathy (HP:0003040) | 2.38360315 |
| 83 | Erythroderma (HP:0001019) | 2.38357588 |
| 84 | Lactic acidosis (HP:0003128) | 2.37220223 |
| 85 | * Recurrent pneumonia (HP:0006532) | 2.34610789 |
| 86 | Progressive microcephaly (HP:0000253) | 2.31731809 |
| 87 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.30724677 |
| 88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.30724677 |
| 89 | Patellar aplasia (HP:0006443) | 2.27134439 |
| 90 | Limited elbow extension (HP:0001377) | 2.26000969 |
| 91 | Exercise intolerance (HP:0003546) | 2.23940739 |
| 92 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16950169 |
| 93 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16950169 |
| 94 | Bronchitis (HP:0012387) | 2.14894909 |
| 95 | Progressive muscle weakness (HP:0003323) | 2.14777360 |
| 96 | Neutropenia (HP:0001875) | 2.11305793 |
| 97 | Respiratory failure (HP:0002878) | 2.10150276 |
| 98 | Irregular vertebral endplates (HP:0003301) | 2.08923062 |
| 99 | * Recurrent lower respiratory tract infections (HP:0002783) | 2.08840451 |
| 100 | Reduced antithrombin III activity (HP:0001976) | 2.06606347 |
| 101 | Lymphoma (HP:0002665) | 2.06445642 |
| 102 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.04921057 |
| 103 | Ankyloglossia (HP:0010296) | 2.04609404 |
| 104 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04232253 |
| 105 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.03585497 |
| 106 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03582267 |
| 107 | Hypertensive crisis (HP:0100735) | 2.02214125 |
| 108 | Cupped ribs (HP:0000887) | 2.00621820 |
| 109 | Vertebral clefting (HP:0008428) | 1.99847546 |
| 110 | Mediastinal lymphadenopathy (HP:0100721) | 1.99826845 |
| 111 | Large eyes (HP:0001090) | 1.98992795 |
| 112 | Lymphopenia (HP:0001888) | 1.97920191 |
| 113 | Increased serum lactate (HP:0002151) | 1.95767127 |
| 114 | Recurrent sinusitis (HP:0011108) | 1.95696791 |
| 115 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93547538 |
| 116 | Ragged-red muscle fibers (HP:0003200) | 1.93475134 |
| 117 | Abnormality of the tricuspid valve (HP:0001702) | 1.91612026 |
| 118 | Sparse scalp hair (HP:0002209) | 1.91350787 |
| 119 | Petechiae (HP:0000967) | 1.91269048 |
| 120 | Abnormality of T cell physiology (HP:0011840) | 1.88259371 |
| 121 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.86859941 |
| 122 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.86859941 |
| 123 | Neoplasm of the adrenal gland (HP:0100631) | 1.86654850 |
| 124 | Neoplasm of the adrenal cortex (HP:0100641) | 1.86228591 |
| 125 | Emotional lability (HP:0000712) | 1.86011082 |
| 126 | Villous atrophy (HP:0011473) | 1.83763434 |
| 127 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.83763434 |
| 128 | Increased hepatocellular lipid droplets (HP:0006565) | 1.82891937 |
| 129 | Severe visual impairment (HP:0001141) | 1.82717032 |
| 130 | Abnormality of the pleura (HP:0002103) | 1.80530809 |
| 131 | Lipid accumulation in hepatocytes (HP:0006561) | 1.80003765 |
| 132 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.79482683 |
| 133 | Hyperthyroidism (HP:0000836) | 1.79133960 |
| 134 | Thrombocytosis (HP:0001894) | 1.78889815 |
| 135 | Prostate neoplasm (HP:0100787) | 1.78698855 |
| 136 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.77738241 |
| 137 | Abnormality of chromosome segregation (HP:0002916) | 1.77314356 |
| 138 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.74847995 |
| 139 | Abnormality of the parathyroid morphology (HP:0011766) | 1.74772653 |
| 140 | Increased nuchal translucency (HP:0010880) | 1.74187955 |
| 141 | Barrel-shaped chest (HP:0001552) | 1.72212784 |
| 142 | Asymmetry of the thorax (HP:0001555) | 1.71860666 |
| 143 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.71091203 |
| 144 | Metaphyseal cupping (HP:0003021) | 1.69755517 |
| 145 | Optic disc pallor (HP:0000543) | 1.68452119 |
| 146 | Thoracic kyphosis (HP:0002942) | 1.67671813 |
| 147 | Prolonged bleeding time (HP:0003010) | 1.67022320 |
| 148 | Enlarged penis (HP:0000040) | 1.66981936 |
| 149 | Increased density of long bones (HP:0006392) | 1.66367990 |
| 150 | Leukocytosis (HP:0001974) | 1.65713255 |
| 151 | Prolonged neonatal jaundice (HP:0006579) | 1.65596209 |
| 152 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.65372728 |
| 153 | Opisthotonus (HP:0002179) | 1.65152103 |
| 154 | Lethargy (HP:0001254) | 1.64943048 |
| 155 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.64893227 |
| 156 | * Skin ulcer (HP:0200042) | 1.63177565 |
| 157 | Abnormal number of erythroid precursors (HP:0012131) | 1.61790892 |
| 158 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.61717539 |
| 159 | * Dehydration (HP:0001944) | 1.61394081 |
| 160 | Spontaneous hematomas (HP:0007420) | 1.61281342 |
| 161 | * External ear malformation (HP:0008572) | 1.60983392 |
| 162 | Bowed forearm bones (HP:0003956) | 1.57930447 |
| 163 | Bowing of the arm (HP:0006488) | 1.57930447 |
| 164 | Macroorchidism (HP:0000053) | 1.57897498 |
| 165 | Aortic regurgitation (HP:0001659) | 1.57329799 |
| 166 | Slow-growing hair (HP:0002217) | 1.57257698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 8.19043263 |
| 2 | VRK2 | 6.08297791 |
| 3 | EEF2K | 6.05643566 |
| 4 | KDR | 4.75313999 |
| 5 | BCKDK | 4.15659053 |
| 6 | KIT | 3.50204541 |
| 7 | ERN1 | 3.10614958 |
| 8 | PIM2 | 2.96216379 |
| 9 | NUAK1 | 2.94144351 |
| 10 | ARAF | 2.81844408 |
| 11 | NEK2 | 2.51358940 |
| 12 | SIK2 | 2.49090012 |
| 13 | NME2 | 2.35969528 |
| 14 | PKN2 | 2.24055246 |
| 15 | RPS6KB2 | 2.10823973 |
| 16 | TESK1 | 2.07194922 |
| 17 | GRK6 | 2.05281406 |
| 18 | STK10 | 1.95616839 |
| 19 | CLK1 | 1.93665550 |
| 20 | CDC7 | 1.91373178 |
| 21 | MAP4K1 | 1.88868385 |
| 22 | STK4 | 1.88705054 |
| 23 | FGFR2 | 1.81483150 |
| 24 | TBK1 | 1.79870273 |
| 25 | SYK | 1.73102832 |
| 26 | CDK4 | 1.68280763 |
| 27 | MAP3K11 | 1.66607020 |
| 28 | NLK | 1.62717152 |
| 29 | CDK12 | 1.61213285 |
| 30 | TAOK3 | 1.57123967 |
| 31 | ZAK | 1.52678395 |
| 32 | FRK | 1.52622376 |
| 33 | MAPK12 | 1.50714986 |
| 34 | MAPK11 | 1.48755110 |
| 35 | BTK | 1.46865597 |
| 36 | BUB1 | 1.46331567 |
| 37 | FES | 1.43711538 |
| 38 | ABL2 | 1.43147083 |
| 39 | LRRK2 | 1.36051710 |
| 40 | MAPKAPK3 | 1.28011545 |
| 41 | SCYL2 | 1.25510742 |
| 42 | CSF1R | 1.25012934 |
| 43 | LIMK1 | 1.24041921 |
| 44 | TRIB3 | 1.19510278 |
| 45 | TESK2 | 1.12172753 |
| 46 | CDK8 | 1.12042697 |
| 47 | PIK3CG | 1.09841335 |
| 48 | MAPK4 | 1.08413302 |
| 49 | PASK | 1.07260428 |
| 50 | MAP4K2 | 1.02887969 |
| 51 | HCK | 1.00773179 |
| 52 | RIPK4 | 0.99896892 |
| 53 | SIK1 | 0.99612352 |
| 54 | TLK1 | 0.98279503 |
| 55 | PBK | 0.95274249 |
| 56 | IKBKE | 0.92123896 |
| 57 | PIM1 | 0.92110061 |
| 58 | MAP3K7 | 0.91885039 |
| 59 | HIPK2 | 0.91071313 |
| 60 | MAPK13 | 0.89729196 |
| 61 | CDK6 | 0.88608255 |
| 62 | DAPK1 | 0.88269831 |
| 63 | MAPKAPK5 | 0.87398073 |
| 64 | WEE1 | 0.86884743 |
| 65 | BMPR2 | 0.86187206 |
| 66 | RPS6KB1 | 0.84718949 |
| 67 | TTK | 0.80291057 |
| 68 | MAP3K8 | 0.79032754 |
| 69 | UHMK1 | 0.77962332 |
| 70 | FGFR3 | 0.77895203 |
| 71 | PLK4 | 0.76229564 |
| 72 | BMPR1B | 0.72649034 |
| 73 | ATR | 0.72402226 |
| 74 | CDK19 | 0.70894256 |
| 75 | RPS6KA5 | 0.68639181 |
| 76 | DYRK2 | 0.65961470 |
| 77 | LYN | 0.65131657 |
| 78 | TGFBR1 | 0.64573195 |
| 79 | CCNB1 | 0.63121705 |
| 80 | SRPK1 | 0.62692084 |
| 81 | MELK | 0.61962084 |
| 82 | TRPM7 | 0.61672301 |
| 83 | RAF1 | 0.59089409 |
| 84 | AURKB | 0.58664309 |
| 85 | BRD4 | 0.57830261 |
| 86 | MARK2 | 0.54961664 |
| 87 | BRSK1 | 0.53719672 |
| 88 | DYRK1B | 0.53669731 |
| 89 | FLT3 | 0.53206525 |
| 90 | CHEK1 | 0.53146808 |
| 91 | CDK9 | 0.51310439 |
| 92 | INSRR | 0.50706680 |
| 93 | CDK2 | 0.49921424 |
| 94 | CDK14 | 0.49381540 |
| 95 | TYK2 | 0.48636448 |
| 96 | BRAF | 0.48370394 |
| 97 | TNK2 | 0.48080968 |
| 98 | MAPKAPK2 | 0.47522493 |
| 99 | ITK | 0.46887281 |
| 100 | IKBKB | 0.46275585 |
| 101 | EIF2AK3 | 0.45750308 |
| 102 | LCK | 0.44444558 |
| 103 | STK3 | 0.44023690 |
| 104 | CDK7 | 0.43784393 |
| 105 | DYRK3 | 0.41999886 |
| 106 | MST4 | 0.41479158 |
| 107 | NEK1 | 0.40972038 |
| 108 | CSNK2A2 | 0.40503365 |
| 109 | PRKCH | 0.39869397 |
| 110 | MTOR | 0.39515738 |
| 111 | PRKCQ | 0.38939352 |
| 112 | PLK1 | 0.38294781 |
| 113 | MARK3 | 0.37860991 |
| 114 | CDK15 | 0.37532592 |
| 115 | VRK1 | 0.37386214 |
| 116 | TRIM28 | 0.37018578 |
| 117 | ATM | 0.36810023 |
| 118 | CDK11A | 0.36256928 |
| 119 | PTK6 | 0.35822908 |
| 120 | CSNK1D | 0.35696848 |
| 121 | ZAP70 | 0.35686028 |
| 122 | CDK18 | 0.35468881 |
| 123 | CHEK2 | 0.34767838 |
| 124 | CSNK2A1 | 0.33235267 |
| 125 | MATK | 0.33022635 |
| 126 | MKNK1 | 0.32755058 |
| 127 | AURKA | 0.32249316 |
| 128 | ICK | 0.32059175 |
| 129 | GRK7 | 0.31957415 |
| 130 | CDK1 | 0.31755573 |
| 131 | TAF1 | 0.31081234 |
| 132 | TXK | 0.30461957 |
| 133 | ALK | 0.28494313 |
| 134 | MAPK7 | 0.27047607 |
| 135 | STK16 | 0.27032461 |
| 136 | PDK1 | 0.27022633 |
| 137 | PIK3CA | 0.26981083 |
| 138 | RPS6KL1 | 0.26847812 |
| 139 | RPS6KC1 | 0.26847812 |
| 140 | PLK3 | 0.26510001 |
| 141 | RPS6KA4 | 0.26293128 |
| 142 | GRK5 | 0.26066320 |
| 143 | TEC | 0.25736683 |
| 144 | BLK | 0.25103918 |
| 145 | PRKCI | 0.24792896 |
| 146 | MAPK14 | 0.24470836 |
| 147 | JAK3 | 0.24021367 |
| 148 | CAMK2G | 0.18556243 |
| 149 | OBSCN | 0.17720311 |
| 150 | MAPK3 | 0.16966785 |
| 151 | PRKD1 | 0.15791973 |
| 152 | IRAK3 | 0.13615818 |
| 153 | AKT1 | 0.13022140 |
| 154 | MAP2K3 | 0.12677814 |
| 155 | PRKDC | 0.12127180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 5.71284338 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.19632484 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.79859774 |
| 4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.48309861 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 3.04653324 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.01725736 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.78721674 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.52214254 |
| 9 | Cell cycle_Homo sapiens_hsa04110 | 2.46623428 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.45976704 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.43157832 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 2.43062029 |
| 13 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.21199540 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.17919705 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 2.16989859 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.08427032 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 2.02127374 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.92481110 |
| 19 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.84878862 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.78375223 |
| 21 | Glioma_Homo sapiens_hsa05214 | 1.72880374 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.70258814 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69698072 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62990722 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.61330719 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.59843711 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.53689054 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51968199 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.46964022 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.45206293 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42828999 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42374401 |
| 33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.41345147 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41064505 |
| 35 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.40927139 |
| 36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.31380591 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.30852447 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30779938 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.30627467 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29872831 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27814157 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.26467636 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.26395564 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25336397 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.24180314 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.22430333 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21479050 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20168507 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18540762 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.16003539 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 1.13041132 |
| 52 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.12371374 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 1.12029695 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11733531 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08707272 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07812028 |
| 57 | Protein export_Homo sapiens_hsa03060 | 1.04340042 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03302358 |
| 59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.03077279 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 1.02954016 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02448093 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01296238 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01122241 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99563004 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94957154 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92390040 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.92270304 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.91498102 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.91131434 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90428406 |
| 71 | Alcoholism_Homo sapiens_hsa05034 | 0.90060367 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89693463 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.88285186 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.86871660 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.86440118 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85348379 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85252968 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84934637 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83565797 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83020041 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82973239 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82011849 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81211782 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81110819 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79938542 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.79783414 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79371402 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.78245105 |
| 89 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78065732 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77838130 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77281433 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77133518 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.76200949 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75639249 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.74294287 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73327663 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72758469 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71127570 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70865347 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70369947 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69737222 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68978871 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68866087 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68773192 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.68537484 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.68403507 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68354911 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67234869 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67126496 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66824472 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65385897 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65128049 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64619110 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64256664 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61508577 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61315775 |
| 117 | RNA degradation_Homo sapiens_hsa03018 | 0.58549342 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56789199 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55614210 |
| 120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55586808 |
| 121 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54061798 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53775811 |
| 123 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52586780 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52351089 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52081717 |
| 126 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51414320 |
| 127 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49397083 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48015054 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47363434 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47223385 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46062957 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45667242 |
| 133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45408621 |
| 134 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45120794 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45076504 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43932647 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43819972 |
| 138 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43798366 |
| 139 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43750053 |
| 140 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43677589 |
| 141 | Tuberculosis_Homo sapiens_hsa05152 | 0.43428846 |
| 142 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42578270 |
| 143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41871805 |
| 144 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41151764 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39370826 |
| 146 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39277277 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38758771 |
| 148 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38093266 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36851473 |
| 150 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35953763 |
| 151 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35907008 |
| 152 | Influenza A_Homo sapiens_hsa05164 | 0.35198346 |
| 153 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.34249050 |
| 154 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31881525 |
| 155 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31703897 |
| 156 | Long-term potentiation_Homo sapiens_hsa04720 | 0.31327703 |
| 157 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30970816 |
| 158 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30781018 |
| 159 | Purine metabolism_Homo sapiens_hsa00230 | 0.30162366 |
| 160 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29964570 |
| 161 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29080645 |
| 162 | Pertussis_Homo sapiens_hsa05133 | 0.28926930 |
| 163 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28680895 |
| 164 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27138039 |
| 165 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24752675 |

